In Vitro Diagnostics Crescent Diagnostics Ltd. Crescent Diagnostics brings in €1.5mm through its Series A round Crescent Diagnostics Ltd. (test for risk of hip fractures) has raised €1.5mm ($2.2mm
by Robert Dunki-Jacobs Excluding skin cancer, colorectal cancer (CRC) is the third most commonly diagnosed cancer in the US and the third leading cause of cancer-related death. According to the Americ